Grant: Master's Award: Canada Graduate Scholarships
University of Alberta
$17,500.00
Pharmacokinetics and Biodistribution Study of Novel Antibody-based Biologic Drugs
FY 2009-10
Summary
Osteoporosis is a disease of bone that often leads to fracture. Its symptoms are loss of bone mass and subsequent decrease in bone mineral density. The probability of being diagnosed with osteoporosis is positively correlated with aging, presumably due to the increase in bone resorption over that of new bone formation. Hence, the aim of our research is to rectify that bone remodelling imbalance by specifically delivering the peptide hormone Calcitonin (known to slow bone loss) directly to bone cells. We plan to achieve this by attaching Calcitonin to an antibody-like vehicle that specifically recognizes bone cells. Therefore, Calcitonin can be directly targeted and delivered to bone for treatment of conditions such as Osteoporosis. We believe that our research would be of great benefit to patients with significant bone loss, such as those suffering from Osteoporosis, Rheumatoid and Osteoarthritis, and some bone cancers, since only a limited number of drugs are currently available to treat those conditions. With the average age of the Canadian population increasing and with Osteoporosis being positively correlated to age, we believe that our research will have a direct and positive impact on the bone health of the Canadian population.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
200350
Name
Lam Michael C
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Pharmacokinetics and Biodistribution Study of Novel Antibody-based Biologic Drugs
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Osteoporosis; Phage Display; Scfv Antibodies
Abstract
Osteoporosis is a disease of bone that often leads to fracture. Its symptoms are loss of bone mass and subsequent decrease in bone mineral density. The probability of being diagnosed with osteoporosis is positively correlated with aging, presumably due to the increase in bone resorption over that of new bone formation. Hence, the aim of our research is to rectify that bone remodelling imbalance by specifically delivering the peptide hormone Calcitonin (known to slow bone loss) directly to bone cells. We plan to achieve this by attaching Calcitonin to an antibody-like vehicle that specifically recognizes bone cells. Therefore, Calcitonin can be directly targeted and delivered to bone for treatment of conditions such as Osteoporosis. We believe that our research would be of great benefit to patients with significant bone loss, such as those suffering from Osteoporosis, Rheumatoid and Osteoarthritis, and some bone cancers, since only a limited number of drugs are currently available to treat those conditions. With the average age of the Canadian population increasing and with Osteoporosis being positively correlated to age, we believe that our research will have a direct and positive impact on the bone health of the Canadian population.
Competitiondate
201002
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lam, Michael C
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~